Search

everythinglearnresearchcommunity

for

Search:↓

Anti-epileptic drugs may cause visual and hair side effects due to enzyme inhibition, especially in genetically predisposed individuals.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Tranexamic acid effectively reduced swelling episodes in a girl with a rare form of hereditary angioneurotic edema.

Clove, cinnamon, and coriander extracts may help reduce blood vessel growth.

Finasteride and dutasteride effectively treat hair loss, with dutasteride showing slightly better results.

Finasteride and dutasteride effectively treat hair loss, with dutasteride showing slightly better results.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Male hormones can decrease the ability of immune cells to fight bacteria.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

These medications for BPH have known risks and may have new side effects.

These medications for BPH have known risks and may have new side effects.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Reducing nerve growth can help skin regenerate after birth.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.

JAK inhibitors can enter the skin through hair follicles using a unique pathway.